Mylan Laboratories News

Craig Morgan, Phil Vassar, Diamond Rio, Due West, Joe Grushecky and Scott Blasey of The Clarks-a Peters Township resident-will be featured in the Mylan Classic's 2012 concert series.

PITTSBURGH, May 24, 2012 /PRNewswire/ -- Mylan Inc. today announced that Mylan Specialty L.P., f/k/a Dey Pharma, L.P., has entered into an agreement with Sunovion Pharmaceuticals Inc., f/k/a Sepracor Inc., to resolve the parties' patent litigation relating to Sunovion's Brovana product.

Craig Morgan, Phil Vassar, Diamond Rio, Due West, Joe Grushecky and Scott Blasey of The Clarks will be featured in the Mylan Classic's 2012 concert series.

PITTSBURGH, May 23, 2012 /PRNewswire/ -- Mylan Inc. today reported that Moody's Investors Service has upgraded the company's credit ratings, including the "Corporate Family Rating," to Ba1 from Ba2.

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Nevirapine Tablets USP, 200 mg.

As Mylan has quietly outperformed the market over the past year, it has flown under the radar as there are much more notable pharmaceutical companies.

There have been several noteworthy developments in the drug space recently, which will likely have a material impact on the companies in this sector and the markets they serve.

Mylan Inc. Sponsors Drug Store News and Pharmacist Society to Provide a New Business Networking Platform for Pharmacy Schools and Students /PRNewswire/ -- The Drug Store News Group, the Pharmacist Society and Mylan Inc., one of the world's leading generics and specialty pharmaceutical companies, are pleased to announce an exclusive sponsorship to ... (more)

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia A $6.4 billion effort to speed U.S. reviews of new drugs and medical devices is a step closer to law as the agreements Mylan Inc.

Joan Orie Melvin's absence may hamstring Supreme Court cases Removing doctors in settlements can deflect oversight Mitt Romney in '65: Prankster with a moral thread Study: 'Good cholesterol' may be overstatement World leaders back mix of austerity and growth Face of politics in South Hills gets new look McCutchen goes deep twice as Pirates beat ... (more)

John Paulson became well known by shorting subprime securities in 2007. The fund manager made $3.5 billion from his bets, becoming a billionaire.

The e-mail address that you supply to use this service will only be used to send the requested article.

PITTSBURGH, May 17, 2012 /PRNewswire/ -- Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc.

BUYINS.NET: Market Maker Surveillance Report. MU, XOM, CTL, MYL, EBR, AXCG, Highest Net Buy Volume With Lowest Price Friction For Wednesday, May 16th 2012 BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday.

Mylan Inc. raised its 2012 earnings forecast on Thursday, just a few weeks after the generic drugmaker reported a 24 percent increase in its first-quarter net income.

Pittsburgh, PA, LYON, France /PRNewswire/ -- Mylan Inc. today announced that it has launched Atorvastatin Calcium Tablets, 10 mg, 20 mg, 40 mg and 80 mg in France, Belgium, the UK, the Netherlands and Ireland.

Drug manufacturer Mylan is set to release Atorvastatin Calcium Tablets in Belgium, France, Ireland, the Netherlands, and the United Kingdom.

MYL ) recently announced that it expects 2012 adjusted earnings in the range of $2.45 to $2.55 per share, up from the previously guided range of $2.30 to $2.50 per share.

's stock had its "buy" rating reiterated by equities research analysts at Goldman Sachs in a research note issued to investors on Friday.

Boeing Co. : Sterne Agee expects Boeing's Investor Day to be positive for the stock, as the firm thinks the company is making significant progress on its new programs.